fredag 4. mars 2011

Conserved core of amyloid fibrils of wild type and A30P mutant alpha-synuclein.

Department for NMR based Structural Biology, Max Planck Institute for Biophysical Chemistry, D-37077, Goettingen, Germany.

The major component of neural inclusions that are the pathological hallmark of Parkinson's disease are amyloid fibrils of the protein a-synuclein (aS). Here we investigated if the disease-related mutation A30P not only modulates the kinetics of aS aggregation, but also alters the structure of amyloid fibrils. To this end we optimized the method of quenched hydrogen/deuterium exchange coupled to NMR spectroscopy and performed two-dimensional proton-detected high-resolution magic angle spinning experiments. The combined data indicate that the A30P mutation does not cause changes in the number, location and overall arrangement of ß-strands in amyloid fibrils of aS. At the same time, several residues within the fibrillar core retain nano-second dynamics. We conclude that the increased pathogenicity related to the familial A30P mutation is unlikely to be caused by a mutation-induced change in the conformation of aS aggregates.

Copyright © 2010 The Protein Society.

View the original article here

Ingen kommentarer:

Legg inn en kommentar